Clinical Trial Update: Endocardial Stem Cells Approach Efficacy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating endocardial stem cell therapy for myocardial ischemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Ischemia

Drugs mentioned

• Endocardial Stem Cell Therapy

Snippet

Sponsor: Meshalkin Research Institute of Pathology of Circulation | Conditions: Myocardial Ischemia | Phase 3 | Status: COMPLETED